Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial-Reference-Cited by-同舟云学术

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

Published:2011-07 Issue:9788 Volume:378 Page:319-327
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Wherrett Diane K,Bundy Brian,Becker Dorothy J,DiMeglio Linda A,Gitelman Stephen E,Goland Robin,Gottlieb Peter A,Greenbaum Carla J,Herold Kevan C,Marks Jennifer B,Monzavi Roshanak,Moran Antoinette,Orban Tihamer,Palmer Jerry P,Raskin Philip,Rodriguez Henry,Schatz Desmond,Wilson Darrell M,Krischer Jeffrey P,Skyler Jay S

Publisher

Elsevier BV

Subject

General Medicine

Reference37 articles.

1. Type 1 diabetes: new perspectives on disease pathogenesis and treatment;Atkinson;Lancet,2001

2. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21–22 October 2001;Palmer;Diabetes,2004

3. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial: a randomized, controlled trial;Ann Intern Med,1998

4. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial;Steffes;Diabetes Care,2003

5. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset: results of a multicentre double-blind trial;Feutren;Lancet,1986

Cited by 309 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydrogel-based approaches to target hypersensitivity mechanisms underlying autoimmune disease;Advanced Drug Delivery Reviews;2024-09

2. Unraveling the Potential of γ-Aminobutyric Acid: Insights into Its Biosynthesis and Biotechnological Applications;Nutrients;2024-08-19

3. Heavy Metals in Autoimmune Diseases: Too Much Noise in Autoimmunity;Autoimmune Disorders;2024-05-03

4. Efficacy of teplizumab for treatment of type 1 diabetes: A meta‐analysis of randomized controlled trials;Diabetes/Metabolism Research and Reviews;2024-05

5. The opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: A systematic review and meta-analysis;Pharmacological Research;2024-05